ABVC
ABVC
NASDAQ · Biotechnology

Abvc Biopharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.06
-0.01 (-0.93%)
As of May 16, 2:21 AM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +2,230.2% upside
Low Target $17.28
Average Target $24.70
High Target $43.03
Current Price $1.06
Current
$1.06
Target
$24.70
$17.28 $24.70 avg $43.03
Scenario Analysis
Bear Case
$17.28
1,530.2%
Low target
Base Case
$24.70
+2,230.2%
Avg target
Bull Case
$43.03
+3,959.4%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$5.48
-80.7% from high
52-Week Low
$0.88
+20.5% from low
Target vs 52W High
$24.70
+350.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%